Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Cash flows from operating activities      
Net income (loss) $ 51,216 $ 24,410  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Provision for loss on receivables 505 648  
Depreciation and amortization 894 895  
Amortization of financing costs 3,354 2,096  
Equity-based compensation 5,499 3,548  
Equity method investments (43,231) 8,914  
Non-cash gain on securitization (6,751) (14,302)  
Gain on sale of receivables and investments (1,227) 9,397  
Changes in receivables held-for-sale (23,574) 0  
Changes in accounts payable and accrued expenses 1,145 (11,291)  
Change in accrued interest on receivables and investments (718) (7,399)  
Other (5,291) (5,261)  
Net cash provided by (used in) operating activities (18,179) 11,655  
Cash flows from investing activities      
Equity method investments (52,862) (140,877)  
Equity method investment distributions received 0 50,143  
Proceeds from sales of equity method investments 0 0  
Purchases of and investments in receivables (96,389) (29,671)  
Principal collections from receivables 25,998 38,276  
Proceeds from sales of receivables 36,370 8,035  
Purchases of investments (4,830) (15,937)  
Principal collections from investments 143 1,048  
Proceeds from sales of investments and securitization assets 7,335 42,920  
Funding of escrow accounts (11,851) (712)  
Withdrawal from escrow accounts 1,126 1,273  
Other (45) 35  
Net cash provided by (used in) investing activities (95,005) (45,467)  
Cash flows from financing activities      
Proceeds from credit facilities 0 126,000  
Principal payments on credit facilities (3,041) (4,347)  
Proceeds from issuance of non-recourse debt 0 15,938  
Principal payments on non-recourse debt (4,830) (83,488)  
Net proceeds of common stock issuances 102,867 114,760  
Payments of dividends and distributions (27,690) (24,363)  
Withholdings on employee share vesting (10,388) (15,968)  
Other (1,027) (990)  
Net cash provided by (used in) financing activities 55,891 127,542  
Increase (decrease) in cash, cash equivalents, and restricted cash (57,293) 93,730  
Cash, cash equivalents, and restricted cash at beginning of period 310,331 106,586 $ 106,586
Cash, cash equivalents, and restricted cash at end of period 253,038 200,316 $ 310,331
Supplemental Cash Flow Information [Abstract]      
Interest paid 30,018 25,436  
Non-cash changes in deferred funding obligations and non-recourse debt (financing activity) (126,139) 0  
Non-cash changes in receivables and investments (investing activity) 127,614 0  
Non-cash changes in residual assets (investing activity) (14,816) (14,302)  
Non-cash changes in escrow accounts (investing activity) $ 2,899 $ 0